Fieldpoint Private Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2K Sell
10
-2
-17% -$426 ﹤0.01% 1198
2022
Q1
$3K Hold
12
﹤0.01% 1417
2021
Q4
$3K Hold
12
﹤0.01% 1402
2021
Q3
$3K Hold
12
﹤0.01% 1381
2021
Q2
$3K Hold
12
﹤0.01% 1327
2021
Q1
$3K Hold
12
﹤0.01% 1318
2020
Q4
$2K Buy
+12
New +$2.07K ﹤0.01% 1325
2019
Q4
Sell
-93
Closed -$13K 682
2019
Q3
$13K Sell
93
-2
-2% -$292 ﹤0.01% 552
2019
Q2
$14K Buy
+95
New +$13.3K ﹤0.01% 577
2018
Q4
Sell
-198
Closed -$26.5K 403
2018
Q3
$30K Hold
198
0.01% 332
2018
Q2
$31K Hold
198
0.01% 332
2018
Q1
$27K Hold
198
0.01% 336
2017
Q4
$27K Hold
198
0.01% 324
2017
Q3
$26K Buy
+198
New +$26.4K 0.01% 486
2017
Q2
Sell
-198
Closed -$24K 276
2017
Q1
$24K Buy
+198
New +$23.4K 0.02% 254

Other funds holding LH

Fieldpoint Private Securities's LH Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Labcorp (LH) stake by 17% in Q2 2022, selling an estimated $426 and leaving 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Fieldpoint Private Securities first reported a position in LH in Q1 2017 and has held it in 15 quarters since. The position peaked at $31K in Q2 2018. 967 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Fieldpoint Private Securities held 10 shares of Labcorp worth $2K as of Q2 2022.
  • Fieldpoint Private Securities sold 2 Labcorp shares in Q2 2022, an estimated $426.
  • Labcorp made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1198 holding.
  • Fieldpoint Private Securities first reported a position in Labcorp in Q1 2017 and has held it in 15 quarters since.
  • Fieldpoint Private Securities's Labcorp position peaked at $31K in Q2 2018.
  • 967 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.